Anti-Siglec-7 antibodies for the treatment of cancer
US11773162B2 · kind B2 · utility
1Cited by
0References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 4, 2017 |
| Grant date | Oct 3, 2023 |
| Priority date | — |
| Expiry date | Jul 12, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods and compositions for the treatment of cancer using anti-Siglec7 antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.